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ABSTRACT		
Nitinol	stent	oversizing	is	frequently	performed	in	peripheral	arteries	to	ensure	a	desirable	
lumen	gain.	However,	the	clinical	effect	of	mis-sizing	remains	controversial.	The	goal	of	this	
study	was	to	provide	a	better	understanding	of	the	structural	and	hemodynamic	effects	of	
Nitinol	 stent	 oversizing.	 Five	 patient-specific	 numerical	 models	 of	 non-calcified	 popliteal	
arteries	were	developed	to	simulate	the	deployment	of	Nitinol	stents	with	oversizing	ratios	
ranging	from	1.1	to	1.8.	In	addition	to	arterial	biomechanics,	computational	fluid	dynamics	
methods	were	adopted	to	simulate	the	physiological	blood	flow	inside	the	stented	arteries.	
Results	showed	that	stent	oversizing	led	to	a	limited	increase	in	the	acute	lumen	gain,	albeit	
at	 the	 cost	 of	 a	 significant	 increase	 in	 arterial	 wall	 stresses.	 Furthermore,	 localized	 areas	
affected	by	 low	Wall	Shear	Stress	 increased	with	higher	oversizing	ratios.	Stents	were	also	
negatively	impacted	by	the	procedure	as	the	fatigue	safety	factors	gradually	decreased	with	
oversizing.	 These	 adverse	 effects	 to	 both	 the	 artery	 walls	 and	 stents	 may	 create	
circumstances	for	restenosis.	Although	the	ideal	oversizing	ratio	is	stent-specific,	this	study	
showed	that	Nitinol	stent	oversizing	has	a	very	small	impact	on	the	immediate	lumen	gain,	
which	contradicts	the	clinical	motivations	of	the	procedure.		
Key	 words:	 self-expanding	 Nitinol	 stents;	 stent	 oversizing;	 stent	 deployment;	 popliteal	
arterial	segment;	patient-specific	arterial	geometry;	curved	arteries;	acute	lumen	gain;	finite	
element	analysis	(FEA);	computational	fluid	dynamics	(CFD)	analysis	
	
	
	
Introduction	
Peripheral	arterial	disease	(PAD)	is	commonly	treated	by	endovascular	means.10	Restenosis	
remains	the	major	drawback	of	endovascular	revascularization	and	may	affect	up	to	70%	of	
patients	 undergoing	 plain	 balloon	 angioplasty	 of	 the	 femoro-popliteal	 (FP)	 arteries.30	 The	
introduction	 of	 self-expanding	 Nitinol	 stents	 has	 reduced	 restenosis	 rates	 within	 these	
arterial	 segments	 to	 about	 40%	 depending	 on	 arterial	 lesion	 morphology.31	 Two	 main	
explanations	 have	 been	 proposed	 to	 explain	 the	 restenosis	 subsequent	 to	 Nitinol	 stent	
placement;	stent	fractures29	and	chronic	irritation	of	arterial	walls	during	or	following	stent	
deployment.11	While	stent	fractures	may	be	explained	by	the	high	mechanical	 loads	acting	
upon	the	stent	during	flexion	of	the	leg9,	arterial	wall	damage	may	result	from	oversizing	of	
Nitinol	stents,	which	 is	 frequently	performed	to	achieve	 large	 luminal	gain	and	to	prevent	
stent	migration.28,40	
Several	investigations	have	been	performed	to	evaluate	the	effect	of	stent	diameter	on	the	
risk	of	restenosis.1,16,22,28,40	A	correlation	between	Nitinol	stent	oversizing	and	restenosis	has	
been	 evaluated	 using	 animal	models,	 for	 which	 oversized	 stents	 have	 been	 implanted	 in	
healthy	arteries	of	Yucatan	swines40,	mini-pigs28,	canines1,16	and	humans.22	Based	on	these	
studies,	 it	 is	 difficult	 to	 assess	 the	 clinical	 effect	 of	Nitinol	 stent	 oversizing	 a	 few	months	
following	endovascular	 intervention.	 In	some	studies,	stent	oversizing	was	associated	with	
adequate	 luminal	 gain	 immediately	 during	 the	 implantation,	 but	 ultimately	 led	 to	 excess	
neointimal	 hyperplasia	 and	 restenosis.1,28,40	 Other	 authors	 reported	 limited	 restenosis	
months	after	implantation	of	oversized	stents.16,22		
A	better	description	of	the	biomechanical	implications	of	oversizing	on	arterial	tissues	may	
help	 to	 understand	 the	 mechanisms	 responsible	 for	 restenosis	 and	 therefore	 help	 the	
clinicians	 to	 select	 the	 appropriate	 stent	 size	 during	 intervention.	 There	 are	 various	
structural	 finite	 element	 (FE)	 analyses	 on	 stent	 deployment.5,6,20,24,39,41	 Similarly,	
computational	 fluid	 dynamics	 (CFD)	 simulations	 have	been	widely	 used	 to	 investigate	 the	
hemodynamic	 properties	 of	 stented	 arteries	 and	 their	 implications	 for	 neointimal	
hyperplasia.3,4,15,18,23,33	However,	 	the	only	numerical	studies	conducted	on	stent	mis-sizing	
were	 found	 to	be	on	balloon-expandable	 stents	deployed	 in	 straight	 cylindrical	models	of	
healthy3,18	 or	 calcified	 coronary	 arteries.37	 Due	 to	 the	 significant	 differences	 in	 their	
deployment	 procedures,	 the	 results	 from	 these	 studies	 could	 not	 be	 adopted	 for	 self-
expandable	 Nitinol	 stents.	 Thus,	 the	 aim	 of	 the	 present	 study	 was	 to	 quantify	 the	
biomechanical	 effects	 of	 Nitinol	 stent	 oversizing	 using	 numerical	 models	 of	 non-calcified	
popliteal	 arteries	 obtained	 from	 patients	 undergoing	 endovascular	 revascularization.	 Two	
main	 aspects	 were	 considered;	 the	 mechanical	 effect	 of	 the	 stent	 on	 arterial	 walls	 and	
hemodynamic	 alterations	 induced	 by	 stents	 of	 varying	 size.	 We	 hypothesized	 that	 wall	
stresses	increase	with	increasing	stent	size,	which	may	lead	to	chronic	arterial	wall	damage.	
Moreover,	 we	 suggested	 that	 the	 presence	 of	 an	 arterial	 curvature	 would	 aggravate	 the	
effects	of	oversizing	by	further	increasing	arterial	stress	levels.	Finally,	we	hypothesized	that	
oversizing	could	 trigger	neointimal	hyperplasia	 in	 the	arterial	walls	by	 reducing	wall	 shear	
stress	(WSS)	and	by	increasing	oscillatory	shear	index	(OSI).		
Materials	and	Methods	
The	 anatomies	 of	 the	 arterial	 models	 were	 obtained	 from	 five	 patients	 (4	 men	 and	 1	
woman;	age,	56-79	years;	mean	age	69	±	9.1	years)	undergoing	intra-arterial	3D	rotational	
digital	 subtraction	 angiography	 (AXIOM-Artis,	 Siemens,	 Germany)	 prior	 to	 endovascular	
revascularization	 of	 FP	 	 arteries.9	 For	 4	 patients,	 the	 investigated	 segment	 of	 the	 arterial	
tract	 started	 from	 the	 descending	 genicular	 artery	 and	 ended	 at	 the	 superior	 genicular	
artery.	For	the	remaining	patient,	the	segment	ended	at	the	inferior	genicular	artery.	Ethics	
committee	 approval	 had	 been	 obtained	 prior	 to	 the	 start	 of	 this	 investigation.	 Further	
information	 about	 the	 patients	 and	 the	 acquisition	 process	 could	 be	 found	 in	 a	 previous	
study.9			
All	 3D	 angiographic	 examinations	 were	 saved	 digitally	 and	 transferred	 to	 a	 workstation	
capable	of	3D	post-processing.	 Following	 the	 segmentation	of	 the	 vasculatures	on	 the	3D	
image	datasets	with	an	image	analysis	software	(Amira	5.2;	FEI	Visualization	Sciences	Group,	
Burlington,	MA,	USA),	 arterial	 centerlines	were	extracted	and	 shortened	 to	only	have	 the	
section	with	the	maximal	curvatures	(mean	length	of	53	mm,	with	a	range	of	47-59.5	mm).	
Each	 centerline	was	described	by	108	points.	 For	each	patient,	 the	FE	mesh	of	 the	artery	
was	 reconstructed	around	these	centerlines	using	a	script	 in	Matlab	 (The	Mathworks	 Inc.,	
Natick,	MA,	USA).	For	each	node	on	the	centerline,	the	script	generated	5	rings,	each	with	
128	nodes.	This	meshing	approach	resulted	in	the	same	number	of	nodes	and	elements	for	
all	the	arterial	models.	Furthermore,	for	longer	centerlines,	the	distance	between	the	rings	
were	adjusted	so	 that	 the	element	size	around	the	region	of	 stent	 implantation	would	be	
the	same	as	the	shorter	centerlines.	Apart	from	the	patient-specific	arteries,	a	sixth	arterial	
model	was	 created	 from	 a	 straight	 centerline	 to	 represent	 a	 generic,	 straight	 artery.	 The	
arteries	 were	 assumed	 to	 have	 a	 circular	 cross	 section	 of	 constant	 diameter.	 Three	
concentric	 arterial	 layers	 were	 reconstructed;	 the	 intima	 (5mm	 –	 5.3mm),	 the	 media	
(5.3mm	–	5.9mm)	and	the	adventitia	(5.9mm	–	6mm).	All	of	the	arterial	models	had	54,874	
linear	 hexahedral	 reduced	 integration	 (C3D8R)	 elements;	 13,696	 elements	 in	 both	 intima	
and	adventitia	and	27,392	elements	in	the	medial	arterial	layer.	The	validity	of	the	mesh	was	
confirmed	 through	 a	 mesh	 sensitivity	 analysis,	 in	 which	 the	 maximum	 circumferential	
stresses	 in	each	 layer	of	 the	artery	changed	by	3%	at	 the	diastolic	and	systolic	points	of	a	
cardiac	cycle.		
The	 material	 model	 adopted	 for	 the	 artery	 was	 an	 anisotropic,	 hyper-elastic	 model	 that	
represented	two	families	of	collagen	fibers.8,12	The	strain	energy	density	function	was	based	
on	the	constitutive	laws	proposed	by	Gasser	et	al.,	which	allows	not	only	the	specification	of	
fiber	orientations,	but	also	the	inclusion	of	fiber	dispersions	within	each	layer.8	The	material	
parameters	 for	 the	model	were	 taken	 from	 experiments	 performed	 on	 non-calcified	 iliac	
arteries		(Table	1).8,12	The	two	families	of	fibers	were	symmetrically	arranged	with	respect	to	
the	 arteries’	 circumferential	 directions.	 In	 accordance	 with	 previous	 findings8,	 the	 fibers	
within	media	were	perfectly	aligned	in	circumferential	direction	(κ	=	0);	whereas	the	fibers	
within	 intima	and	adventitia	were	modeled	as	slightly	 (κ	=	0.02)	and	highly	dispersed	 (κ	=	
0.226),	respectively.		
The	arterial	models	were	implanted	with	two	commercially	available,	self-expanding	stents:	
Astron-Pulsar	and	Astron	(Biotronik	AG,	Bülach,	Switzerland).	Both	stents	were	made	of	the	
same	 shape	 memory	 Nitinol,	 whose	 material	 coefficients	 were	 provided	 by	 the	
manufacturer	 (Table	2).	Nevertheless,	 the	 stents	exhibited	different	mechanical	behaviors	
due	to	their	different	designs,	with	the	Astron	having	larger	strut	width,	thickness	and	outer	
diameter	 (119µm,	 245µm	 and	 5	 mm,	 respectively)	 than	 the	 Astron-Pulsar	 stent	 (80µm,	
155µm	and	3.5	mm,	 respectively).	FE	meshes	of	both	stents	were	produced	with	173,160	
and	 91,248	 C3D8R	 elements	 for	 Astron-Pulsar	 and	 	 Astron,	 respectively.	 The	 number	 of	
elements	 used	 to	mesh	 the	 stents	were	 determined	 by	 sensitivity	 analyses,	 in	which	 the	
maximum	 principal	 strain	 values	 changed	 less	 than	 2.5%	 in	 the	 stents’	 crimped	
configurations.	
Due	 to	 the	 discontinuities	 induced	 by	 the	 large	 number	 of	 complex	 contact	 interactions	
between	 several	 components	 of	 the	model,	 the	 structural	 analyses	were	 conducted	with	
Abaqus/Explicit	 (Dassault	 Systemes,	 Simulia	 Corp.,	 RI,	USA).	 A	 semi-automatic	 stable	 time	
increment	of	4x10-6	was	defined	 to	 control	mass	 scaling.	This	 increment	ensured	 that	 the	
ratio	 of	 kinetic	 to	 internal	 energy	 in	 the	 system	 remained	 below	 5%	 to	 avoid	 dynamic	
effects,	 which	 guaranteed	 that	 the	 analysis	 remained	 quasi-static.To	 leave	 the	 stents	
constraint	 free	 and	 let	 them	 find	 their	 own	 mechanical	 equilibriums,	 all	 displacement	
boundary	conditions	were	applied	onto	the	nodes	of	two	rigid	cylinders	that	were	meshed	
with	4	node	quadrilateral	shell	elements,	with	reduced	integration	(S4R).	They	surrounded	
the	inner	and	outer	surfaces	of	the	stents	and	acted	as	expansion	and	crimp	tools	(Fig.	1).	
While	the	undeformed	diameter	of	the	expansion	tool	corresponded	to	the	inner	diameter	
of	 the	 Astron-Pulsar	 stent;	 the	 initial	 size	 of	 the	 crimp	 tool	was	 sufficiently	 large	 to	 only	
contact	 with	 the	 stents	 when	 this	 one	 reaches	 its	 unconstrained	 diameter.	 The	 contact	
between	the	surfaces	was	defined	as	a	frictionless,	hard	contact.	Additionally,	arteries	were	
fixed	at	both	ends	with	the	exception	of	the	local	radial	directions.	A	total	of	four	cases	were	
considered	 for	each	artery,	where	 stents	with	unconstrained	diameters	of	5.5,	 6,	 7	 and	9	
mm	were	used.	
Prior	 to	 the	 oversizing	 analyses,	 the	 validity	 of	 the	 arterial	 model	 had	 been	 evaluated.	
Rectangular	strips	of	each	individual	arterial	layer	were	subjected	to	uniaxial	extension	and	
their	mechanical	behaviors	in	axial	and	circumferential	directions	had	been	compared	with	
published	 experimental	 data.13	 Another	 evaluation	 of	 the	 proposed	 arterial	 model	 was	
performed	by	 calculating	 the	 compliance	of	 the	 artery.	 The	 compliance	was	 calculated	 as	
the	ratio	of	the	maximum	nominal	strain	to	the	maximum	pressure	change	during	a	cardiac	
cycle	and	the	numerically	obtained	value	was	compared	with	in	vivo	measurements.35	The	
precision	 of	 the	models	 used	 to	 simulate	 the	 stents	was	 also	 evaluated.	 The	 radial	 force	
generated	 by	 the	 stents	 was	 calculated	while	 crimping	 the	 stents	 to	 a	 1.8	mm	 diameter	
followed	by	an	expansion	to	their	unconstrained	diameters	of	9	mm.	The	radial	 force	was	
compared	with	experimental	measurements	provided	by	the	stent	manufacturer.	Finally,	in	
order	to	ensure	a	5	mm	lumen	at	a	mean	blood	pressure	of	120	mmHg,	the	arterial	models	
were	run	through	an	iterative	process7,	in	which	the	arterial	expansion	was	estimated	under	
the	 target	 pressure.	 The	 unloaded	 arterial	 geometry	 obtained	 following	 the	 last	 iteration	
was	considered	as	the	stress-free	configuration.	
Accurate	 calculation	 of	 the	 deployment	 requires	 considering	 the	 complete	 stress-strain	
history	of	the	Nitinol	stents.	Therefore,	full	stent	deployment,	involving	the	preconditioning	
of	the	stents,	was	performed	for	all	cases	(Fig.	1).	In	the	first	step,	the	only	active	contact	in	
the	 model	 was	 between	 the	 inner	 surface	 of	 the	 stent	 and	 the	 outer	 surface	 of	 the	
expansion	tool.	By	radially	displacing	each	node	of	the	rigid	tool,	the	stent	was	expanded	to	
its	desired	unconstrained	diameter.	At	 this	 stage,	 the	 stent	was	 subjected	 to	annealing;	 a	
procedure	 used	 to	 remove	 the	 existing	 stresses,	 while	 preserving	 the	 deformed	 shape.	
Subsequently,	the	previous	contact	pair	of	stent-expansion	tool	was	replaced	with	a	contact	
interaction	between	the	outer-surface	of	the	stent	and	the	inner-surface	of	the	crimp	tool.	
In	 the	next	 step,	 the	stent	was	crimped	 to	 its	deployment	diameter	 (1.25	mm	for	Astron-
Pulsar	 and	 1.88	mm	 for	 the	Astron	 stent)	 by	 applying	 displacements	 to	 the	 nodes	 of	 the	
crimp-tool.	During	this	step,	a	uniform	pressure	load	of	120	mmHg	was	applied	to	the	inner	
surface	of	the	arteries	to	expand	the	lumen	diameters	to	exactly	5	mm,	which	corresponded	
to	 the	 average	 lumen	 diameter	 of	 healthy	 arteries	 in	 physiological	 blood	 pressures.34	
Following	crimping,	the	crimp	tool	was	deformed	into	the	shape	of	the	arterial	centerline	to	
simulate	stent	 insertion.	The	contact	pair	was	modified	 to	 include	an	 interaction	between	
the	outer-surface	of	the	stent	with	the	inner-surface	of	the	artery	in	addition	to	the	existing	
stent-crimp	 tool	 pair.	 Consequently,	 during	 the	 tool’s	 radial	 expansion	 to	 its	 final	
configuration	 (which	 depends	 on	 the	 unconstrained	 stent	 diameter	 for	 each	 oversizing	
case),	the	stent	smoothly	detached	from	the	tool	when	it	came	into	contact	with	the	inner	
wall	 of	 the	 artery.	 After	 deployment,	 a	 cyclic	 blood	 pressure	 of	 ±40	mmHg	 (i.e.	 pressure	
between	80mmHg	and	160mmHg)	was	applied	to	the	inner	surface	of	the	artery	for	a	total	
of	3	cycles	to	simulate	a	case	of	isolated	systolic	hypertension,	which	has	been	reported	to	
be	the	most	frequent	form	of	hypertension	in	patients	suffering	from	PAD.27	
Blood	 flow	 computations	 investigated	 the	 effects	 of	 different	 oversizing	 ratios	 and	 the	
performances	 of	 both	 stents	 in	 a	 patient-specific	 artery.	 Following	 stent	 deployment,	 the	
deformed	meshes	 of	 the	 artery	 and	 the	 stents	 were	 exported	 from	 Abaqus	 as	 open	 file	
formats	 (.obj)	 and	 converted	 to	 surface	 stl	 models	 using	 Solidworks	 2013	 (Dassault	
Systemes,	 Simulia	 Corp.,	 RI,	 USA).	 These	 geometries	were	 used	 for	 the	 generation	 of	 the	
computational	 volumetric	 grids,	 consisting	 of	 approximately	 4.5	 million	 tetrahedral	
elements,	 in	 ANSYS	 ICEM	 CFD	 (ANSYS	 Inc.,	 Pittsburg,	 PA).	 The	 computational	 domain	 is	
adequately	 refined	near	 the	 stent	 struts	 and	different	 sizes	of	 the	 computational	 grid	are	
tested	in	a	steady-state	solution	to	ensure	that	the	results	are	 independent	of	the	applied	
spatial	discretization	scheme.	The	analyses	were	performed	with	the	finite	volume	code	CFX	
14.0	(ANSYS	Inc.,	Pittsburg,	PA),	where	the	following	continuity	and	Navier-Stokes	equations	
are	discretized	with	second	order	accuracy	in	space	and	time:	
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where	u	is	velocity	(m/s),	t	is	time	(s),	ρ	is	density	(kg/m3)	and	p	and	µ	are	pressure	(Pa)	and	
dynamic	viscosity	(Pa.s),	respectively.	
Physiological	blood	 flow	was	simulated	as	a	 transient	 flow	condition	by	applying	 the	MRI-
measured	volumetric	flow	rate	at	the	inlet	of	the	artery	(Fig.	5).36	The	artery	outlet	was	set	
to	have	zero	pressure	and	a	no-slip	boundary	condition	was	prescribed	at	the	arterial	wall	
and	stent	struts.	Consequently,	the	outlet	was	extended	enough	to	minimize	the	effects	of	
boundary	conditions	on	the	accuracy	of	the	simulations.	As	the	plug-flow	profile	is	applied	
at	 the	 inlet,	 it	was	 also	 extended	 to	 reach	 a	 realistic	 blood	 flow	 profile.	 This	way,	 a	 fully	
developed	parabolic	flow	profile	was	guaranteed.	Blood	was	modeled	as	an	incompressible	
Newtonian	fluid	with	a	density	of	1050	kg/m3	and	a	viscosity	of	3.5x10-3	Pa.s.19	Three	cardiac	
cycles	were	calculated	using	a	time	step	size	0.01	s.	Each	time	step	was	assumed	converged,	
when	residuals	reduced	to	10-6	of	their	initial	values.	
A	relation	between	restenosis	and	arterial	stresses	has	previously	been	suggested,	with	high	
arterial	stresses	acting	as	a	predictor	of	restenosis.38	On	the	other	hand,	the	lack	of	an	exact	
stress	 threshold	 that	 marks	 the	 beginning	 of	 such	 a	 process	 would	 only	 lead	 to	 indirect	
suggestions	for	a	safe	oversizing	ratio.	A	better	approach	would	be	to	define	an	oversizing	
limit	 based	 on	 tissue	 failure,	 which	 could	 be	 correlated	 by	 experimental	 findings.13	 As	 a	
result,	 the	 maximum	 circumferential	 stresses	 in	 each	 layer	 were	 compared	 with	 their	
respective	 ultimate	 experimental	 stresses	 to	 specify	 the	 most	 failure-prone	 layer	 in	 the	
artery.	Subsequently,	the	maximum	circumferential	stresses	in	this	layer	were	evaluated	to	
establish	a	correspondence	between	arterial	stresses	and	unconstrained	stent	diameters.		
The	 application	 of	 cyclic	 blood	 pressures	 following	 deployment	 provided	 the	 means	 to	
conduct	fatigue	analyses	on	the	stents.	The	main	aim	was	to	calculate	the	factor	of	safety	
(FOSNitinol)	of	the	Nitinol	stents,	which	represented	the	structural	integrity	of	the	implanted	
device.	Since	Nitinol	is	strain	driven,	mean	strains	and	strain	amplitudes	were	calculated	at	
all	 integration	points.	Using	the	strain	amplitude	obtained	from	the	3rd	cycle	and	a	Nitinol	
endurance	limit	of	0.4%21,	FOSNitinol	was	determined	as:	
ampNitinolFOS ε
4.01
= 	 	 	 	 (3)	
where	εamp	represents	the	maximum	strain	amplitude	and	was	calculated	as	the	difference	
of	the	maximum	principal	strains	between	the	systolic	and	diastolic	blood	pressures.	A	FOS	
value	below	+1	corresponds	to	material	failure.		
Spatial	and	temporal	variations	of	arterial	endothelial	WSS	are	believed	to	play	a	critical	role	
in	 hemodynamics	 of	 intact	 and	 stented	 arteries.25	WSS	parameters	 such	 as	 Time-Average	
WSS	 (TAWSS)	 and	 Oscillatory	 Shear	 Index	 (OSI)	 were	 derived	 from	 the	 numerically-
calculated	 transient	WSS	 field	 using	 an	 in-house	MATLAB	 script	 and	 visualized	 by	 Tecplot	
(Tecplot	 Inc.,	 Bellevue,	 WA).	 To	 obtain	 results	 independent	 of	 the	 temporal	 cycles	 and	
simulation	initialization,	the	data	of	only	the	last	cardiac	cycle	was	evaluated.	TAWSS,	as	a	
crucial	factor	to	evaluate	the	hemodynamic	status	of	the	stented	artery,	was	defined	as14:	
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where,	τ
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w
	is	the	CFD-calculated	magnitude	of	the	instantaneous	WSS	vector	(Pa)	and	T	is	
the	 duration	 of	 one	 cardiac	 cycle	 (s).	 To	 include	 the	 effect	 of	 transient	 oscillation	 of	 the	
blood	flow,	OSI	was	defined	as14:	
⎟⎟
⎟
⎟
⎠
⎞
⎜⎜
⎜
⎜
⎝
⎛
−=
∫
∫
T
w
T
w
dt
dt
OSI
0
01
2
1
τ
τ
!
!
		 	 	 (5)	
To	provide	a	 less-sensitive	hemodynamic	performance	 indicator,	 the	surface	area	exposed	
to	low	TASSW	and	high	OSI	was	normalized	with	respect	to	the	luminal	surface	area.	
Results	
The	 preliminary	 simulations	 have	 been	 performed	 to	 validate	 the	 numerical	 models	
proposed	 for	 the	 artery	 and	 the	 Nitinol	 stents.	 The	 compliance	 of	 the	 arterial	 tract	
calculated	with	 the	model	was	 7.1%	mmHg-1	 x	 10-2,	which	 corresponded	 to	 experimental	
measurements	 acquired	 on	 the	 popliteal	 artery	 of	 subjects	 without	 evidence	 of	 PAD.35	
Simulations	 of	 the	 arterial	 tissues	 showed	 a	 good	 agreement	 with	 uniaxial	 traction	
experiments	 conducted	 on	 each	 individual	 arterial	 layer	 (Fig.	 2).13	 In	 addition,	 the	 radial	
forces	 of	 the	 stents	 calculated	 with	 the	 model	 corresponded	 to	 the	 forces	 measured	
experimentally	 (Fig.	 2).	 Furthermore,	 mechanical	 comparison	 of	 the	 two	 stents	 revealed	
that	the	Astron	had	a	higher	radial	force	compared	to	the	Astron-Pulsar	during	its	expansion	
from	1.8	to	7	mm,	thereby	making	it	stiffer	at	the	point	of	contact	(about	5	mm)	with	the	
artery	(Fig.	2).			
Following	 stent	 deployment,	 results	 indicated	 that	 adventitia	 was	 the	 arterial	 layer	
supporting	most	of	 the	mechanical	 load.	Moreover,	adventitia	was	 the	most	 failure-prone	
layer,	reaching	up	to	60%	of	its	ultimate	stresses13	for	a	normal-sized	stent	and	up	to	100%	
of	 the	 ultimate	 stresses	 when	 the	 oversizing	 ratio	 was	 1.8.	 For	 all	 cases,	 the	 maximum	
circumferential	 stresses	 in	 this	 layer	 increased	 non-linearly	 with	 respect	 to	 the	
unconstrained	diameters	of	 the	Astron-Pulsar	 stent	 (Fig.	3).	 Furthermore,	 the	 relationship	
between	acute	luminal	gain	and	stent	diameters	was	also	observed	to	be	non-linear.	Thus,	
when	 stents	 of	 5.5,	 6,	 7	 and	 9	mm	 diameters	were	 implanted,	 acute	 luminal	 gains	were	
reported	to	be	7%,	10%,	11%	and	11.5%,	respectively	(Fig.	3).		
The	non-linear	increase	in	arterial	stresses	and	lumen	gains	was	similar	for	both	stents	in	all	
arteries	(Fig.	3).	Due	to	its	higher	radial	force,	the	Astron	stent	produced	higher	stresses	in	
the	arteries	when	compared	with	the	Astron-Pulsar	stent	at	each	pressure	level	(Fig.	4).	 In	
the	straight	arterial	model,	the	maximum	difference	between	the	stresses	produced	by	the	
two	 stents	 was	 about	 30%	 for	 both	 normal-sized	 and	 oversized	 stents.	 This	 difference	
increased	to	more	than	40%	in	patient-specific	arteries	(Fig.	4).	The	artery	also	had	a	greater	
expansion	with	 the	 Astron	 stent,	 in	which	 the	maximum	 increase	 of	 the	 lumen	 gain	was	
1.5%	and	2.5%	for	straight	and	patient-specific	arteries,	respectively	(Fig.	4).	
Regardless	of	the	arterial	geometry,	the	fatigue	behavior	of	the	Astron-Pulsar	stent	showed	
similar	 behaviors.	 Increasing	 the	 unconstrained	 stent	 diameters	 led	 to	 an	 increase	 in	 the	
mean	strains	at	the	integration	points;	with	the	average	maximum	values	being	reported	as	
1.70%	 ±	 0.51%,	 3.38%	 ±	 0.89%,	 6%	 ±	 0.07%	 and	 7.07%	 ±	 0.11	 for	 5.5,	 6,	 7	 and	 9	 mm,	
respectively	 (Fig.	5).	 In	contrast,	 there	was	a	smaller	 increase	 in	 the	strain	amplitude	with	
increasing	 oversizing	 ratios.	 Consequently,	 the	 factor	 of	 safety	 of	 the	 stent	was	 found	 as	
5.28	±	0.1,	4.94	±	0.11,	3.64	±	0.27	and	1.18	±	0.11	for	5.5,	6,	7	and	9	mm,	respectively.	A	
similar	 gradual	 decrease	 in	 the	 safety	 factor	 of	 the	 stent	was	 observed	 for	 the	Astron	 as	
well.	
For	 all	 deployment	 cases	 and	 for	 both	 stent	models,	 spatial	 structure	 of	 blood	 flow	 and	
instantaneous	patterns	of	WSS	were	 found	 to	be	 complex	 and	 varying	during	 the	 cardiac	
cycle	(Fig.	6).	Throughout	the	cardiac	cycle	and	for	the	time-integrated	parameter,	localized	
areas	of	atheroprone	 low	WSS	(less	 than	5%	of	maximum	WSS	 i.e.	<	0.5	Pa)	were	seen	 in	
regions	of	flow	separation,	e.g.	near	the	stent	struts	and	inner	side	of	curved	artery.	Regions	
of	 high	 WSS,	 on	 the	 other	 hand,	 were	 likely	 to	 occur	 on	 the	 outer	 side	 of	 the	 arterial	
curvature	and	on	the	in-lumen-protruded	side	of	the	stent	struts.	Independent	of	the	stent	
stiffness,	length	and	geometry,	larger	areas	were	exposed	to	low	WSS	at	proximal	portions	
of	 the	 stented	 segments.	 Furthermore,	 the	 distribution	 of	OSI,	 as	 a	measure	 of	 temporal	
WSS	change,	in	both	stents	showed	similar	traits	with	the	TAWSS	distribution.	High	values	of	
OSI	(more	than	20%	of	maximum	OSI	i.e.	>0.1)	were	seen	in	the	vicinity	of	stent	struts,	inter-
strut	 connectors,	 proximal	 segment	 of	 stented	 artery	 and	 distal	 inner	wall	 of	 the	 curved	
artery.		
A	direct	comparison	of	all	cases	showed	that	increasing	the	stent-induced	arterial	diameter	
would	 raise	 the	normalized	 surface	 area	 exposed	 to	 low	TAWSS	 (less	 than	0.5	 Pa),	which	
was	 concurrently	 more	 pronounced	 for	 the	 cases	 stented	 with	 the	 Astron	 (Fig.	 7).	 In	
addition,	 the	 deployment	 of	 Astron	 definitively	 assured	 that	 the	 surface	 area	 exposed	 to	
high	atheroprone	values	of	OSI	would	be	bigger	than	with	the	Astron-Pulsar	(Fig.	7).	No	clear	
relation	between	the	oscillatory	features	of	blood	flow	and	different	lateral	expansion	rates	
was	observed.		
Discussion	
Nitinol	stent	oversizing	is	commonly	performed	during	endovascular	procedures;	however,	
currently,	stent	sizing	mostly	relies	on	the	expertise	of	the	clinicians	and	is	defined	by	stent	
manufacturers	 and	 not	 by	 objective	 criteria.	 While	 oversizing	 a	 stent	 will	 undoubtedly	
increase	acute	luminal	gain,	 it	can	also	create	a	hostile	chronic	environment	for	the	artery	
through	 stent-to-arterial	 wall	 interactions,	 which	may	 ultimately	 lead	 to	 arterial	 damage,	
neointimal/adventitial	 hyperplasia	 and	 restenosis.28,40	 With	 previous	 clinical	 studies	
reporting	controversial	findings	on	the	subject3,16,22,28,	the	efficacy	of	oversizing	remains	an	
issue	 to	 be	 answered.	 Thus,	 to	 improve	 the	 understanding	 of	mechanical	 effects	 of	 stent	
oversizing	in	the	popliteal	arterial	tract,	numerical	analyses	have	been	performed	within	the	
present	investigation.		
The	 hypothesis	 behind	 stent	 oversizing	 is	 that	 oversized	 stents	 will	 limit	 possible	 arterial	
restenosis	due	to	acute	 lumen	enlargement.	However,	results	of	this	study	showed	a	non-
linear	relationship	between	the	lumen	gain	and	oversizing	ratio	(Figures	3	and	4).	Increased	
oversizing	led	to	a	small	lumen	increase,	while	generating	rapidly	increasing	arterial	stresses	
(Figures	3	and	4).	This	mismatch	between	the	limited	lumen	gain	and	elevating	stresses	can	
be	illustrated	by	a	3%	lumen	vs.	30%	stress	increase	for	the	Astron-Pulsar	stent	(4%	vs.	33%	
for	the	Astron)	when	the	stent-to-artery	ratio	is	transitioned	from	1.1	to	1.2.	Therefore,	our	
results	 suggest	 that	 instead	 of	 providing	 an	 additional	 lumen	 gain,	 stents	 with	 higher	
oversizing	ratios	 inflict	greater	chronic	arterial	damages	through	 increased	chronic	arterial	
stresses.		
A	 comparison	 between	 the	 numerical	 and	 experimental	 results	 indicated	 that	 increased	
oversizing,	the	level	of	arterial	stresses	came	close	to	the	failure	limits	of	the	tissues,	which	
have	 been	 obtained	 via	 uniaxial	 extension	 tests.13	 Independent	 of	 the	 stent	 design,	
adventitia	was	found	to	be	the	most	vulnerable	layer	due	to	its	highly	nonlinear	mechanical	
response	 at	 pressures	 above	 80	 mmHg.32	 The	 high	 risk	 of	 failure	 in	 this	 layer	 further	
suggests	that	normal	sized	stents	are	more	favorable	to	protect	arterial	walls	from	chronic	
damage	and,	consequent,	neoadventitial	hyperplasia.32	
Results	 of	 the	 numerical	 calculations	 showed	 that	 both	 the	 maximum	 arterial	
circumferential	 stresses	 and	 the	 luminal	 gains	 increased	 non-linearly	 with	 respect	 to	 the	
unconstrained	stent	diameters	 regardless	of	arterial	geometries	and	stent	designs	 (Fig.	3).	
Comparisons	 between	 straight	 and	 patient-specific	 geometries	 showed	 that	 the	 latter	
exhibited	 slightly	 less	 pronounced	 non-linear	 increase	 of	 the	mechanical	 parameters	with	
increased	 oversizing.	 This	 may	 be	 explained	 by	 distinctive	 deformations	 exerted	 onto	
different	 arterial	 geometries	 during	 stent	 deployment.	While	 the	 straight	 artery	was	 only	
displaced	 radially,	 the	 curved	 arteries	 were	 subjected	 to	 straightening	 alongside	 radial	
expansion.	This	effect	not	only	caused	an	overall	increase	of	the	circumferential	stresses	for	
each	 oversizing	 ratio,	 but	 also	 led	 to	 higher	 stress	 differences	 between	 oversized	 and	
normal-sized	arteries.	
The	successful	outcome	of	an	endovascular	procedure	not	only	lies	in	selecting	the	correct	
stent	 size,	 but	 also	 in	 selecting	 the	 correct	 stent	 design.	 In	 the	 present	 study,	 the	
disproportionate	increase	between	lumen	gain	and	arterial	stresses	for	successive	oversizing	
ratios	was	similar	for	both	stents	(Fig.	4).	On	the	other	hand,	oversizing	the	Astron	stent	to	
the	ratio	of	1.2	 increased	the	risk	of	failure	considerably	when	compared	with	the	Astron-
Pulsar	stent.	Furthermore,	a	maximum	difference	of	2.5%	was	observed	between	the	lumen	
gains	achieved	at	this	oversizing	ratio	(Fig.	4).	This	value	remains	small	when	compared	with	
their	corresponding	stress	difference	of	37%	(Fig.	4).	Therefore,	this	mismatch	between	the	
changes	 in	 the	 stresses	 and	 lumen	 diameters	 suggests	 that	 radial	 force	 would	 have	 an	
impact	 on	 the	 processes	 observed	 during	 clinical	 follow-up,	 as	 stents	 with	 higher	 radial	
forces	would	likely	inflict	more	chronic	irritation	to	arterial	walls	when	compared	with	their	
less	stiff	counterparts.	
Individual	patient	anatomies	in	the	present	study	all	showed	different	curvatures.	However,	
no	 relation	 between	 the	 fatigue	 behavior	 of	 either	 the	 Astron-Pulsar	 or	 the	 Astron	 and	
arterial	 geometries	 was	 observed.	 Instead,	 the	 stents	 performed	 similarly	 for	 all	 curved	
arteries.	 This	 may	 be	 explained	 by	 the	 fact	 that	 an	 identical	 systolic-diastolic	 pressure	
behavior	was	applied	to	all	models.24	The	safety	factor	of	the	Astron-Pulsar	stent	was	found	
to	 decrease	 with	 increasing	 oversizing	 ratio,	 which	 can	 be	 explained	 by	 the	 higher	
deformations	exhibited	by	oversized	stents	due	their	incomplete	expansions	at	deployment.	
Although	the	calculated	fatigue	criterion	remained	below	the	failure	level,	stents	with	9	mm	
diameters	 came	 close	 to	 the	 Nitinol	 endurance	 limit	 of	 0.4%	 (Fig.	 5)21,	 without	 even	
considering	 the	 mechanical	 forces	 acting	 on	 the	 stent	 due	 to	 the	 physiological	 loading	
present	 in	 lower	 limb	 arteries9.	 This	 result	 suggests	 that	 oversizing	 increases	 the	 risks	 of	
stent	failures,	which	has	been	directly	related	with	restenosis.17			
Physiological	stressors	such	as	near-wall	flow,	which	directly	perturb	intra-	and	extracellular	
signaling,	proved	to	be	a	reliable	predictor	for	local	biological	responses	of	stented	arteries2.	
Thus,	 studying	 the	 hemodynamic	 performance	 of	 implanted	 stents	 and	 considering	
procedural	variabilities,	such	as	oversizing,	could	be	used	to	provide	clinicians	with	accurate	
observations	on	the	causes	of	adverse	biological	effects.	Local	flow	patterns	are	proved	to	
affect	 the	 neointimal	 formation,	 in-stent	 restenosis	 and	 thrombosis	 in	 stented	 arteries.	
Therefore,	 computed	 indices	 of	 flow	 were	 calculated	 here	 to	 support	 the	 hypothesized	
drawback	 of	 stent	 oversizing.	 The	 critical	 values	 of	 low	 WSS	 and	 high	 OSI,	 which	 are	
reported	to	correlate	with	adverse	clinical	outcomes25,	were	found	to	be	similar	to	already	
published	 studies.26	 Stent	 oversizing	 considerably	 perturbed	 the	 local	 flow	 patterns,	
specifically	 the	 near-wall	 flow,	 due	 to	 the	 abrubt	 change	 in	 the	 proximate	 bounding	
geometry.	The	procedure	was	found	to	increase	the	normalized	surface	area	exposed	to	low	
TAWSS,	 leading	 to	 a	 large	 area	 of	 the	 stented	 artery	 to	 be	 susceptible	 to	 unfavorable	
biological	 responses.	 The	 abrupt	 change	 of	 arterial	 size	 and	 the	 expanded	 cross-section	
would	decrease	the	blood	flow	and	the	WSS	in	the	vicinity	of	the	stented	wall	(Fig.	6).	For	
cases	where	 significant	 lumen	gain	 is	 not	 achieved,	 this	would	depress	 the	hemodynamic	
efficiency	of	 the	oversized	stent	and	seriously	question	 its	clinical	expediency.	 In	contrast,	
the	 larger	 surface	 area	 exposed	 to	 high	OSI	was	 not	 affected	 by	 the	 stent-to-artery	 ratio	
(Fig.	7).	This	may	be	mainly	related	to	the	specific	shape	of	the	stent	and	curvature	of	the	
artery,	 wherein	 the	 secondary	 flow	 generated	 by	 the	 arterial	 curvature	 and	 recirculation	
zones	induced	by	the	stent	will	have	a	combinatory	effect	on	the	oscillatory	characteristics	
of	the	blood	flow.	For	the	cases	implanted	with	the	Astron	stent,	larger	deformations	were	
induced	in	the	artery	walls	around	the	stent	struts,	which	resulted	in	a	larger	alteration	of	
near-wall	flow	compared	to	the	more	flexible	Astron-Pulsar	stent.	Consequently,	computed	
indices	of	flow	such	as	velocity	and	WSS	are	more	affected	when	stiffer	stents	are	used.	In	
conclusion,	 stent-induced	 oversizing	 of	 the	 arterial	 wall,	 independent	 of	 the	 stent	 type,	
would	deteriorate	the	hemodynamic	performance	of	peripheral	stents,	wherein	the	arteries	
fitted	with	stiffer	stents	become	more	vulnerable.		
The	 validity	 of	 the	 proposed	 arterial	 model	 was	 verified	 by	 comparing	 the	 numerical	
simulations	with	published	experimental	data.	The	individual	behaviors	of	each	arterial	layer	
obtained	via	traction	simulations,	as	well	as	the	overall	compliance	of	the	artery,	matched	
well	with	existing	measurements	(Fig.	2).13,35	Furthermore,	the	mechanical	behavior	of	the	
adventitia	is	similar	to	previous	reports32,	as	it	became	the	mechanically	predominant	layer	
when	the	physiological	blood	pressure	of	13.3	kPa	is	exceeded.	These	comparisons	indicated	
that	 the	 present	 arterial	 model	 is	 appropriate	 to	 evaluate	 arterial	 stenting.	 Finally,	 the	
immediate	 lumen	 gain	 values	 obtained	 from	 the	 deployment	 simulations	were	 compared	
with	a	clinical	investigation	that	performed	Nitinol	stent	oversizing	in	the	femoral	arteries	of	
Yucatan	swines40.	These	clinical	findings	compared	favorably	with	the	lumen	gains	obtained	
in	 our	 study	 for	 high	 oversizing	 ratios	 (>1.4).	 On	 the	 other	 hand,	 numerical	models	 with	
lower	oversizing	ratios	(<1.4)	predicted	a	larger	lumen	gain	,	which	can	be	attributed	to	the	
difference	between	the	numerical	and	clinical	arterial	diameters	prior	to	stenting.		
Several	 limitations	 to	 the	present	 study	need	 to	be	discussed.	Only	 healthy	 arteries	were	
modeled	 and	 stented,	 while	 stents	 are	 generally	 implanted	 in	 diseased	 arteries.	 The	
inclusion	 of	 plaques	 into	 the	 model	 would	 not	 only	 change	 the	 stress/strain	 values,	 but	
would	also	have	an	impact	on	the	location	of	maximum	stress/strain	concentrations	in	the	
arterial	models.	However,	based	on	current	understanding,	deployed	stents	usually	overlap	
with	 the	 non-obstructed	 parts	 of	 an	 artery,	 thereby	 exerting	 potential	 effects	 caused	 by	
stent	oversizing	on	both	healthy	and	diseased	sections.	Moreover,	pre-clinical	investigations	
have	so	 far	used	healthy	animal	arteries	 to	 investigate	 the	effects	of	oversizing.	Thus,	 the	
results	could	easily	be	compared	to	validate	the	numerical	models.	Only	two	stent	designs	
were	used	in	this	study.	Although	the	effects	of	oversizing	are	not	expected	to	change	with	
different	 stent	 designs,	 the	 level	 of	 stress	 and	 lumen	 expansion	 may	 show	 differences.	
Performing	 similar	 calculations	 for	 different	 designs	 could	 work	 towards	 achieving	 an	
average	value	for	a	safe	oversizing	ratio.	Since	the	present	study	focused	on	the	parametric	
evaluation	 of	 the	 stenting	 procedure,	 the	 same	material	model	 was	 used	 for	 all	 patient-
specific	arteries.	Due	to	this	parametric	approach,	the	conclusion	on	the	effect	of	oversizing	
should	 remain	 identical	 for	 each	 patient,	 although	 the	 exact	 level	 of	 strain	 may	 differ.	
Finally,	the	residual	strains	for	the	arteries	were	not	modeled,	which	may	suggest	a	possible	
overestimation	 of	 the	 arterial	 stresses.	 Nonetheless,	 the	 nonlinear	 stress	 behavior	 with	
increasing	 stent	 diameters	 would	 be	 the	 same.	 The	 accuracy	 of	 blood	 flow	 simulations	
depends	on	the	chosen	boundary	conditions.	In	order	to	obtain	more	realistic	results,	direct	
experimental	measurements	 should	 be	 used	 to	 define	 the	 boundary	 conditions	 for	 blood	
velocity	or	pressure	at	 the	 inlet	and	outlet.	 In	 this	 study,	a	generic	dataset	obtained	 from	
MRI	measurement	was	applied	at	the	inlet	of	the	domain.	However,	a	simplified	boundary	
condition	was	used	at	the	outlet	with	a	zero	pressure.	To	limit	the	error	introduced	by	this	
approximation,	the	outlet	was	extended	to	maintain	realistic	flow	profiles.		
The	 effects	 of	 Nitinol	 stent	 oversizing	 in	 geometrically	 patient-specific	 popliteal	 arteries	
were	evaluated	through	numerical	analyses.	A	gradual	 increase	of	the	stent-to-artery	ratio	
from	 1.1	 to	 1.8	 showed	 the	 development	 of	 both	 the	 structural	 and	 hemodynamic	
properties	 of	 arteries	 with	 respect	 to	 the	 normal	 and	 oversized	 stent	 diameters,	 while	
providing	 the	 framework	 for	 fatigue	 analyses	 of	 the	 stents.	 The	 results	 showed	 that		
oversizing	 had	 a	 very	 limited	 impact	 on	 the	 immediate	 lumen	 gains	 achieved	 following	
stenting.	At	the	same	time,	transition	to	a	higher	oversizing	ratio	led	to	a	significant	increase	
in	 structural	 and	 WSS	 in	 arteries,	 which	 can	 be	 associated	 with	 arterial	 damage	 and	
disruption	in	the	blood	flow.	Since	self-expanding	stents	will	continuously	apply	radial	forces	
to	the	arterial	walls	in	order	to	reach	their	nominal	diameters,	these	damages	will	continue	
to	accumulate,	creating	a	mechanical	environment	prone	to	induce	restenosis.	Therefore,	to	
increase	 the	success	 rate	of	an	endovascular	procedure	 in	a	FP	arterial	 tract	 that	 includes	
healthy	 popliteal	 segments,	 clinicians	 should	 take	 care	 not	 to	 oversize	 Nitinol	 stents	 and	
allow	them	to	contribute	to	a	late	lumen	gain	in	the	arteries.	
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	 Adventitia	 Media	 Intima	
C10	(kPa)	 7.64	 15	 31	
k1	(kPa)	 996.6	 4	 51	
k2	 524.6	 2.3	 1.1	
δ1	=	δ2	(°)	 50	 7	 5	
κ	 0.226	 0	 0.02	
Table	1:	Material	parameters	for	the	individual	layers	of	the	artery;	intima,	media	and	
adventitia	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Austenite	elasticity	EA	(MPa)	 65,000	
Austenite	Poisson’s	ratio	νA	 0.33	
Martensite	elasticity	EM	(MPa)	 23,500	
Martensite	Poisson’s	ratio	νM	 0.33	
Transformation	strain	εL	 0.046	
Loading	 LT )( δ
δσ 					[MPa	T-1]	 0	
Start	of	transformation	loading	 SLσ 	(MPa)	 465	
End	of	transformation	loading	 ELσ 	(MPa)	 535	
Reference	temperature	T0( C° )	 37	
unloading	 UT )( δ
δσ 	 0	
Start	of	transformation	unloading	 SUσ 	(MPa)	 227	
End	of	transformation	unloading	 EUσ 	(MPa)	 187	
Start	of	transformation	stress	in	compression	 SCLσ 	(MPa)	 582	
Volumetric	transformation	strain LVε 	 0.046	
Table	2:	Material	parameters	for	the	Nitinol	model	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	Captions	
Figure	1:	Example	of	the	preconditioning	and	deployment	of	a	Nitinol	stent	 into	a	patient-
specific	 artery.	 By	 radially	 displacing	 the	 nodes	 of	 the	 expansion	 tool	 (not	 shown),	 the	
Astron-Pulsar	 stent	 is	 expanded	 to	 its	 unconstrained	 diameter	 of	 7mm	 (top-left).	 After	
annealing,	 the	 stent	 is	 crimped	 to	 its	 deployment	 diameter	 of	 1.2	 mm	 by	 radial	
displacement	 of	 the	 nodes	 of	 the	 crimp	 tool	 (top-middle).	 The	 insertion	 in	 the	 patient’s	
artery	 is	 achived	by	 a	 displacement-controlled	 ddeformation	of	 the	 crimp	 tool	 is	 into	 the	
shape	 of	 the	 arterial	 midline	 (top-middle).	 The	 crimp-tool	 is	 then	 expanded	 to	 its	 initial	
diameter,	which	corresponds	to	the	deployement	of	the	stent	when	its	detached	from	the	
tool	to	contact	the	arterial	walls	(top-right).	Following	deployment,	strains	are	concentrated	
at	the	outer	sides	of	the	struts	(bottom-left)	and	stress	distribution	in	different	layers	of	the	
artery	demonstrates	the	load-carrying	behavior	of	the	adventitia	(bottom-right)	
Figure	2.	Uniaxial	extension	tests	of	the	adventitial	layer	excised	in	circumferential	(top	left)	
and	 axial	 (top	 right)	 directions	 are	 numerically	 modeled	 and	 the	 resultant	 stress-strain	
relationships	(red)	are	found	to	be	in	range	of	the	diverse	mechanical	behaviors	obtained	via	
experiments	(blue).	The	numerically	obtained	radial	forces	(green)	of	the	Astron-Pulsar	stent	
correspond	 to	 the	 experimental	 measurements	 (black)	 (bottom	 left).	 	 Additionally,	 the	
comparison	of	the	radial	forces	of	Astron-Pulsar	(black)	and	Astron	(green)	stents	highlights	
the	stiffer	nature	of	the	Astron	stent	(bottom	right).	
Figure	 3:	 The	 average	 maximum	 arterial	 circumferential	 stresses	 of	 the	 patient-specific	
arteries	(red)	exceed	the	stress	 levels	observed	in	a	straight	artery	(black)	and	show	a	less	
emphasized	 non-linear	 behavior	 for	 all	 blood	 pressure	 values	 (range:	 80	 mmHg	 –	 160	
mmHg)	(left).	Regardless	of	the	arterial	geometries,	a	very	small	lumen	gain	is	achieved	by	
oversizing	the	stents	(right).	
Figure	 4:	 The	 stent	 with	 a	 higher	 radial	 force,	 Astron	 (green),	 was	 found	 to	 create	
significantly	 higher	 stress	 levels	 than	 the	Astron-Pulsar	 stent	 (red)	 (left).	 In	 comparison,	 a	
very	limited	increase	in	lumen	gain	is	observed	to	create	a	mismatch	in	arterial	stress-lumen	
relationship	(right).	Regardless	of	the	stent	designs,	a	very	small	 lumen	gain	is	achieved	by	
oversizing	the	stents	(right).	
Figure	 5:	 The	 fatigue	 behavior	 of	 the	 Pulsar	 stent	 when	 deployed	 into	 a	 geometrically	
accurate	artery	with	unconstrained	stent	diameters	of	5	mm	(top	left),	6	mm	(top	right),	7	
mm	(bottom	left)	and	9	mm	(bottom	right):	As	the	oversizing	ratio	 is	 increased,	the	strain	
amplitude	 of	 more	 points	 are	 found	 to	 migrate	 towards	 the	 Nitinol	 safety	 limit	 of	 0.4;	
thereby	decreasing	the	safety	factor	of	the	stent.	
Figure	6:	Instantaneous	pattern	of	wall	shear-stress	(WSS)	distribution	on	stented	popliteal	
artery	at	different	instants	of	a	cardiac	cycle	marked	by	solid	red	line	on	a	flow	rate	profile	
inset.	WSS	is	shown	at:	(A)	t	=	0.13	second	(B)	t	=	0.44	second	and	(C)	t	=	0.64	second.	Panel	
(D)	 shows	how	 the	 symmetric	 velocity	profile	 is	distorted	 toward	 the	outer	wall	owing	 to	
arterial	curvature.	This	affects	the	WSS	distribution	considerably.		
Figure	7.	Normalized	 surface	area	exposed	 to	 time-averaged	wall	 shear	 stress	 (TAWSS)	of	
less	than	0.5	Pa	(left)	and	oscillatory	shear	 index	(OSI)	of	more	than	0.1	(right).	Oversizing	
leads	 to	 larger	 areas	 being	 exposed	 to	 low	 TAWSS	 and	 more	 prominent	 atheroprone	
conditions	at	the	arterial	wall,	which	is	more	noticeable	for	the	cases	with	the	stiffer	Astron	
stent.	 On	 the	 other	 hand,	while	 the	 local	mechanical	 environment	 induced	 by	 oscillatory	
characteristics	of	blood	flow	significantly	increase	with	the	deployment	of	Astron,	they	are	
not	directly	effected	by	stent	oversizing.	
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